Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Trisalus Life Sciences, Inc. (TLSI) AI Forecast

Our AI analyzed Trisalus Life Sciences, Inc.. Create a free account and follow it to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$TLSI Neutral Signal Full forecast available
Sign Up Free

Trisalus Life Sciences, Inc. (TLSI) Stock Forecast 2025

Trisalus Life Sciences, Inc. (TLSI) AI Stock Price Forecast & Investment Analysis

Trisalus Life Sciences, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Trisalus Life Sciences, Inc. (TLSI) - Comprehensive Stock Analysis & Investment Research

Deep dive into Trisalus Life Sciences, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on July 28, 2026, 9:17 a.m. (UTC)

Trisalus Life Sciences, Inc. Investment Summary

When evaluating whether Trisalus Life Sciences, Inc. (TLSI) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Trisalus Life Sciences, Inc. (TLSI) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. . With a market capitalization of $267 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Trisalus Life Sciences, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Trisalus Life Sciences, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Trisalus Life Sciences, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Trisalus Life Sciences, Inc.

Sign Up Free
Corporate Identity

Trisalus Life Sciences, Inc. (Stock Symbol: TLSI) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Trisalus Life Sciences, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Trisalus Life Sciences, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Trisalus Life Sciences, Inc....

Unlock Full Company Profile

Get complete details about Trisalus Life Sciences, Inc.

Sign Up Free
Revenue & Growth Analysis

Trisalus Life Sciences, Inc. generates annual revenues of $44 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Trisalus Life Sciences, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Trisalus Life Sciences, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Trisalus Life Sciences, Inc....

Unlock Financial Analysis

Get complete financial metrics for Trisalus Life Sciences, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Trisalus Life Sciences, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Trisalus Life Sciences, Inc. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Trisalus Life Sciences, Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-20 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Asset Utilization Efficiency

Asset turnover ratio of 0.63x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Current ratio of 5.78 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Trisalus Life Sciences, Inc. (TLSI) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Trisalus Life Sciences, Inc. stock analysis.

Deep dive into Trisalus Life Sciences, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Trisalus Life Sciences, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Trisalus Life Sciences, Inc.:

P/B Ratio 20.81x
Market Cap $267M
Book Value/Share $0.21
Revenue/Share $0.73
FCF/Share $-0.33
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Trisalus Life Sciences, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Trisalus Life Sciences, Inc.:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Trisalus Life Sciences, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Trisalus Life Sciences, Inc.: A current ratio of 5.78 indicates strong liquidity.

Current Ratio 5.78x
Quick Ratio 5.46x
D/E Ratio 4.54x
Financial Leverage 5.54x
Interest Coverage -7.4x
Working Capital $56M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Trisalus Life Sciences, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Trisalus Life Sciences, Inc.: Free cash flow of $-20M indicates cash challenges that need attention.

Free Cash Flow -$20M
FCF/Sales -45.2%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Trisalus Life Sciences, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Trisalus Life Sciences, Inc.: An asset turnover of 0.63x suggests room for improvement in asset utilization.

Asset Turnover 0.63x
Receivables Turnover 8.6x
Fixed Assets Turnover 23.1x
Days Sales Outstanding 42 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Trisalus Life Sciences, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Trisalus Life Sciences, Inc.: With annual revenue of $44M, Trisalus Life Sciences, Inc. represents a smaller but potentially high-growth operation.

Income Statement
Total Revenue $44M
Operating Income -$1M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 68%
Cash & Short-term Investments 57%
Total Liabilities 58%
Accounts Receivable 5%
Inventory 4%
Dividend & Shareholder Information
Shares Outstanding 61M

Latest Trisalus Life Sciences, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Trisalus Life Sciences, Inc. (TLSI) stock price and investment outlook.

📰 Loading...

Trisalus Life Sciences, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Trisalus Life Sciences, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM ██% $11M x 1.9x
AEMD ██% $1M x 0.3x
ALUR ██% $6M x x
AMIX ██% $2M x 0.3x
ANGO ██% $570M x 3.3x
ANIK ██% $201M x 1.5x
AORT ██% $1.25B 107.3x 2.8x
APYX ██% $163M x 12.7x
ARAY ██% $27M x 0.6x
ATEC ██% $1.33B x x
ATRC ██% $1.90B 182.0x 3.7x
AURX ██% $49M x x
BAX ██% $12.02B x 2.0x
BBNX ██% $713M x 2.6x
BDX ██% $43.79B 38.5x 1.8x
BEAT ██% $29M x 45.9x
BJDX ██% $1M x 0.3x
BSX ██% $67.58B 19.0x 2.6x
BTCY ██% $2M x x
BVS ██% $838M 29.4x 4.4x
BWAY ██% $632M x x
CARL ██% $311M x 3.4x
CERS ██% $596M x 8.8x
CLPT ██% $438M x 23.2x
CODX ██% $7M x 0.5x
CTSO ██% $23M x 10.3x
CVRX ██% $129M x 4.4x
DCTH ██% $412M 733.5x 3.7x
DRIO ██% $55M x 0.9x
DRTS ██% $1.07B x 13.9x
DXCM ██% $28.31B 30.4x 9.6x
EBRCZ ██% $137M x 14.4x
EMBC ██% $204M 1.8x x
FEMY ██% $9M x 1.3x
FOFA ██% $27M 173.9x 28.2x
GCTK ██% $2M x x
GIPL ██% $170K x 0.3x
GKOS ██% $8.87B x 13.2x
GMED ██% $10.59B 18.1x 2.2x
GUTS ██% $127M x 6.0x
HAE ██% $3.62B 37.2x 4.5x
HRGN ██% $18M x 200.7x
HTFL ██% $2.18B x 7.7x
IART ██% $1.50B x 1.4x
ICCM ██% $10M x 1.1x
ICUI ██% $4.04B 87.1x 1.9x
IDXG ██% $43M 1.8x 1.9x
INBS ██% $4M x 0.5x
INSP ██% $1.47B 11.2x 1.9x
IRMD ██% $1.22B 51.5x 12.3x
IRTC ██% $3.68B x 22.9x
IVF ██% $2M x 0.1x
KIDS ██% $469M x 1.4x
KMTS ██% $1.33B x 5.1x
KRMD ██% $188M x 11.1x
LMAT ██% $2.26B 36.2x 5.6x
LNSR ██% $65M 2.2x 6.0x
LUCD ██% $172M x 43.1x
LUNG ██% $52M x 1.1x
LYRA ██% $890K x x
MBOT ██% $117M x 1.6x
MCAG ██% $37M x x
MDAI ██% $52M x x
MDLN ██% $70.74B 84.5x 6.3x
MDNC ██% $59M 65.1x 10.0x
MDXG ██% $634M 20.7x 2.6x
MMED ██% $4.59B x 1.3x
MMM ██% $87.46B 29.2x 29.6x
MMSI ██% $4.54B 32.6x 2.8x
MODD ██% $12M x 1.0x
NEPH ██% $37M 47.9x 3.5x
NMTC ██% $16M x 3.1x
NPCE ██% $498M x 34.4x
NSPR ██% $32M x 0.7x
NUMD ██% $2M x x
NVCR ██% $2.32B x 6.9x
NVNO ██% $7M x 0.3x
NXGL ██% $4M x 1.0x
NYXH ██% $147M x x
OBIO ██% $213M x 5.2x
ODYY ██% $710K x x
OFIX ██% $443M x 1.0x
OSRH ██% $15M x 0.1x
OSUR ██% $280M x 0.9x
PAVM ██% $32M x 0.8x
PDEX ██% $175M 14.6x 3.9x
PEN ██% $12.49B 73.0x 8.5x
PETV ██% $25M x 11.4x
PFSA ██% $930K x x
PLRZ ██% $29M x 1.1x
PLSE ██% $2.11B x 31.9x
PMI ██% $9M x 2.4x
PODD ██% $11.08B 36.6x 8.5x
PRCT ██% $999M x 2.9x
PREM ██% $2M x 0.6x
PROF ██% $249M x 4.2x
PSTV ██% $26M x 2.2x
PYPD ██% $77M x 7.0x
QTEX ██% $49M x 21.3x
RCEL ██% $142M x x
RDGL ██% $29M x 10.7x
RMD ██% $27.83B 18.3x 4.3x
RTGN ██% $75M x x
RVP ██% $20M x 0.3x
SGHT ██% $254M x 4.7x
SGP ██% $698M x 2.8x
SIBN ██% $728M x 4.1x
SIGY ██% $160K x x
SINT ██% $9M x 10.2x
SKIN ██% $95M x 1.7x
SNOA ██% $6M x 1.8x
SNWV ██% $51M 3.2x 27.7x
SOLV ██% $13.85B 9.7x 2.8x
SRTS ██% $50M x 1.1x
SSII ██% $681M x 12.5x
SSKN ██% $0.00M x 0.0x
STIM ██% $121M x 9.1x
STME ██% $6M x x
STVN ██% $5.45B x x
SYK ██% $129.82B 38.9x 5.7x
TCMD ██% $635M 31.3x 2.9x
TELA ██% $27M x x
TFX ██% $5.91B x 1.9x
TLSI ██% $267M x 20.8x
TMCI ██% $258M x 3.4x
TNDM ██% $1.15B x 8.7x
TNON ██% $3M x 1.7x
UFPT ██% $1.89B 27.5x 4.3x
USAQ ██% $5M 10.4x 3.0x
UTMD ██% $217M 20.0x 1.8x
VTAK ██% $1M x 0.1x
VVOS ██% $6M x x
VYCO ██% $2M x x
WST ██% $23.20B 41.1x 7.8x
XAIR ██% $4M x 0.6x
XTNT ██% $60M 33.0x 1.2x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Trisalus Life Sciences, Inc. Stock Forecast

How accurate are Trisalus Life Sciences, Inc. stock predictions?

Our AI model shows a -13% Spearman correlation coefficient for TLSI predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Trisalus Life Sciences, Inc. stock price forecasts?

Our analysis considers Trisalus Life Sciences, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Trisalus Life Sciences, Inc. a good investment in 2025?

Based on our AI analysis, Trisalus Life Sciences, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Trisalus Life Sciences, Inc. forecasts updated?

Trisalus Life Sciences, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Trisalus Life Sciences, Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...